There was plenty at stake in this week’s midterm elections, and not just in terms of political wins and losses. With congress now divided—Democrats took back control of the House and Republicans extended their majority in the Senate—the implications are significant... Read more »
Earlier this month, GM CEO Mary Barra told the crowd at a financial conference that her company was on track to unveil a ridesharing service in 2019 that would be powered by autonomous vehicles. It sounded like pretty big news, but... Read more »
A product that reduces emissions from farm animal waste? There’s now a drug for that.
The FDA has approved an Elanco (NYSE: ELAN) drug developed to reduce the ammonia gas released from cattle manure. The agency says its Tuesday decision... Read more »
Esperanto Technologies, a startup AI chip developer that has operated mostly below the radar since its founding in 2014, announced this week that it raised $58 million in a Series B fundraising round.
Mountain View, CA-based Esperanto is vying with... Read more »
Eli Lilly hasn’t been shy about making deals to build up its cancer immunotherapy pipeline, and its latest one is with NextCure, a biotech with technology that finds molecular targets to drive an immune response to tumors.
The Indianapolis pharmaceutical giant... Read more »
Artificial intelligence and automation are helping legacy industries across the country become more innovative and efficient.
An Indianapolis startup called DriverReach is doing just that for the trucking industry, where driver shortages have been plaguing logistics operations, says founder and CEO... Read more »
Scale Computing, an Indianapolis IT startup serving smaller businesses, distributed enterprises, and retailers around the world, has raised $34.8 million in a Series F funding round.
Co-founder and CEO Jeff Ready says technology hardware giant Lenovo was the largest contributor... Read more »
The gene-editing technology CRISPR-Cas9 is opening up new research avenues all the time, such as giving drug developers a cheaper, faster way to knock out genes in tumor cells.
Studies of CRISPR-Cas9 to treat human disease are about to start,... Read more »
In some ways, the biggest software acquisition of all time could be a yawner.
IBM’s planned $34 billion deal to acquire open-source software maker Red Hat is a hefty price to pay to give its cloud computing business a shot in... Read more »
Autonomous vehicle developers rely heavily on navigational technology that maps the complex terrain of roads, curbs, signs, and people that their cars have to thread through.
Google, as it develops its smart home systems, is turning to a company that already... Read more »
Facebook (NASDAQ: FB) shares gained nearly 3 percent Tuesday, and ticked up further in after-hours trading following the release of a third quarter earnings report that showed some strengths as well as shortfalls. Investors have been concerned about the social... Read more »
Stantt wants to make standard sizing anything but.
“Traditional sizing only fits 15 percent of guys,” says Matt Hornbuckle, the startup’s founder and co-CEO. “Twins come in and get different sizes.”
To connect guys with a shirt that fits well, the... Read more »
It wasn’t too long ago that pharma companies were abandoning the development of RNA interference medicines. But there are some small signs that interest has been rekindled. And Dicerna Pharmaceuticals, which recently ended a long-running legal spat with the field’s leader,... Read more »